index: hide

#### Monitoring During Initial Therapy
- Response assessment after 2 cycles, then every 2–4 cycles with CT of known sites of disease with or without contrast or when clinically indicated.

#### Monitoring During Subsequent Therapy
- Response assessment with CT of known sites of disease with or without contrast every 6–12 weeks. Timing of CT scans within Guidelines parameters is a clinical decision.